UNSPSC 85551463: Replacement of left cornea with nonautologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to replacement of left cornea with nonautologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 08R93KZ

UNSPSC 85551463 Replacement of left cornea with nonautologous tissue substitute, percutaneous approach is a Commodity code that maps poorly to actual state and local procurement activity. The recent opportunities tagged under this code involve occupational medical surveillance, independent disability medical evaluations, health plan benefits administration, pharmacy management, temporary clinical staffing, and youth detention healthcare — none of which involve corneal transplantation or ophthalmic surgical procedures. The code's nominal scope (a specific surgical technique) does not align with what state and local governments are actually soliciting under this tag, and the opportunities reflect administrative healthcare services, benefits management, and staffing coordination rather than medical devices or surgical interventions.

The recent activity spans Arizona, California, Florida, and Washington, with issuing bodies including the City of Phoenix Retirement Office, City of Long Beach, Washington State Department of Transportation (ferries division), Harris County Juvenile Probation Department, Collier County Board of County Commissioners, and County of Santa Clara Health System. Representative recent opportunities include the Washington State Ferries RFP for occupational medical surveillance services (RFP20260825, due October 9, 2026) and the City of Phoenix's RFP for independent medical evaluation services supporting public safety pension disability determinations (RTMRFP26001, due October 16, 2026). The code shows minimal relevance to medical device procurement or surgical supply chains and does not represent a viable market segment for vendors in orthopedic or ophthalmic implants.